Aristeia Capital’s Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share PHYT.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-325,000
Closed -$19.5K 491
2024
Q3
$19.5K Hold
325,000
﹤0.01% 302
2024
Q2
$17.8K Hold
325,000
﹤0.01% 283
2024
Q1
$10.4K Hold
325,000
﹤0.01% 265
2023
Q4
$21.8K Buy
+325,000
New +$24.4K ﹤0.01% 140

Other funds holding PHYT.WS

Aristeia Capital's PHYT.WS Position: Q4 2024 in Review

Aristeia Capital sold out of Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (PHYT.WS) in Q4 2024, closing a stake of 325,000 shares — an estimated $19.5K sold.

Aristeia Capital first reported a position in PHYT.WS in Q4 2023 and held it in 4 quarters. The position peaked at $21.8K in Q4 2023. 3 funds tracked by Wall St. Rank hold PHYT.WS as of Q4 2024.

  • Aristeia Capital reported no remaining Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position as of Q4 2024 after selling out during the quarter.
  • Aristeia Capital sold 325,000 Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share shares in Q4 2024, an estimated $19.5K.
  • Aristeia Capital first reported a position in Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in Q4 2023 and held it in 4 quarters.
  • Aristeia Capital's Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position peaked at $21.8K in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share as of Q4 2024.

Based on Aristeia Capital's 13F filing for Q4 2024, filed 14 Feb 2025.